Medtronic plc (MDT)
About Medtronic plc
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $33.5B
- Net income
- $4.7B
- Total assets
- $91.7B
- Market cap
- $104.9B
- Gross margin
- 65.0%
- Operating margin
- 17.8%
- Net margin
- 13.3%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $36.4B
- Cost of revenue
- $12.7B
- Gross profit
- $23.6B
- Operating expenses
- $17.2B
- Operating income
- $6.5B
- Income tax
- $1.3B
- Net income
- $4.8B
- EPS (basic)
- $3.75
- EPS (diluted)
- $3.73
Balance sheet
- Total assets
- $93.0B
- Current assets
- $24.8B
- Total liabilities
- $43.0B
- Current liabilities
- $11.7B
- Shareholders’ equity
- $50.1B
Cash flow
- Operating cash flow
- $7.3B
- Investing cash flow
- -$2.9B
- Financing cash flow
- -$4.8B
- Net cash flow
- -$270.0M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $104.9B
- P/E ratio
- 22.3
- EPS (diluted)
- $3.73
- Dividend yield
- 3.46%
- Shares outstanding
- 1.3B
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 1, 1972
Medtronic plc (MDT) Stock Price
- Profitable — net income of $4.7B in FY2025.
- Revenue grew 15% from FY2022 to FY2026.
- Gross margin of 65.0%, net margin 13.3%.
- Trading 21% below its 52-week high.
- Pays a dividend yielding about 3.46% annually.
- Valued at a price-to-earnings (P/E) ratio of 22.3.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Medtronic plc.
Write a review
News about Medtronic plc
News & sentiment via Polygon.io
Medtronic plc: frequently asked questions
Is Medtronic plc an American company?
Medtronic plc is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Is Medtronic plc publicly traded?
Yes — Medtronic plc is a publicly traded company. Its stock trades under the ticker symbol MDT on the NYSE.
What does Medtronic plc do?
Medtronic plc is an American Medical Devices company in the Health & Beauty sector.
When was Medtronic plc founded?
Medtronic plc was founded in 1949.
